Dose Tapering Study of Adalimumab in Psoriasis

Clinical trial NCT04028713 · TERMINATED

Trial details

NCT number: NCT04028713
Sponsor: University Hospital, Ghent
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Psoriasis Vulgaris

Start date: 2021-02-16
Primary completion: 2022-03-22
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.